Ignite Creation Date:
2025-12-25 @ 12:09 AM
Ignite Modification Date:
2025-12-30 @ 5:27 PM
Study NCT ID:
NCT01035658
Status:
TERMINATED
Last Update Posted:
2021-10-28
First Post:
2009-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01
Start Date Type:
None
Primary Completion Date:
2012-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-17
First Submit QC Date:
None
Study First Post Date:
2009-12-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-12-16
Results First Submit QC Date:
None
Results First Post Date:
2015-05-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-04
Last Update Post Date:
2021-10-28
Last Update Post Date Type:
ACTUAL